Renub

    Proton Therapy Market in Russia & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers

    Excel: 4 Hours
    PDF: 4 Hours
    Mar 2017
    Pages: 50

    Get Free 10% Customization in This Report

    The untapped market of proton therapy in Russia would be more than US$ 3 Billion during forecast period. IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, has started installation of the Cyclone® 230 in 2016 for a new proton therapy center. The acceptance of the first treatment room is planned for the end of 2017. The proton therapy center in Dimitrovgrad will be IBA’s first in the Russian Federation and is expected to treat up to 1,200 patients per year according to IBA.   

    Proton Therapy Market in Russia & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers provides a detailed assessment of the Proton Therapy Market in Russia. In this report we have studied the market in two parts a) Actual Market and b) Untapped Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies.

    a) Actual Market is the current market which is already present

    b) Untapped Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.


    Key Questions Answered in the Report?   
     
        What is the Proton Therapy Market in Russia & its growth potential in Future?  
    •    What is the Untapped Proton Therapy Market in Russia and its Future?  
    •    How many Proton Therapy Facilities are operating in Russia?    
        How many Proton Therapy Facilities are in construction and planning phase?   
        What is the number of people being treated in these Proton Therapy Centers yearly?  
        Is Proton Therapy Treatment being covered in the Reimbursement policy of Russia?   
        What are the sales of Proton Therapy Companies Globally (IBA, Varian, Elekta)?

    Key Companies Covered

    1.    IBA (Overview, Sales Analysis)
    2.    Varian Medical Systems (Overview, Sales Analysis)
    3.    Elekta (Overview, Sales Analysis)

    1.    Executive Summary

    2.    Russia Proton Therapy Market – Actual & Untapped Market
    2.1    Russia – Proton Therapy Market

    2.2    Russia – Untapped Proton Therapy Market

    3.    Russia Proton Therapy Patient Number – Actual and Untapped
    3.1    Russia – Patients Treated with Proton Therapy Actual Numbers & Forecast

    3.2    Russia – Patients with Proton Therapy Untapped Numbers & Forecast

    4.    Russia – List of Proton Therapy Centers

    5.    Russia – Proton Therapy Treated Patients by Centers
    5.1    Moscow (ITEP) Proton Therapy Center

    5.2    St. Petersburg Proton Therapy Center

    5.3    Dubna (JINR, 2) Proton Therapy Center

    6.    Proton Therapy – Reimbursement Policies
    6.1    Proton Therapy Reimbursement Policies for Patients

    6.2    Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

    7.    Components of a Standard Proton Therapy Center
    7.1    Proton Accelerator
    7.1.1    Synchrotrons (example: LLUMC at Loma Linda) 
    7.1.2    Cyclotrons (example: MGH Boston) 
    7.1.3    Synchrocyclotrons (examples: Orsay, Uppsala) 
    7.1.4    Linacs (Rome) 
    7.1.5    H-minus Synchrotrons
    7.1.6    Separated Sector Cyclotrons
    7.1.7    Super-conducting Cyclotrons
    7.1.8    Fast Cycling Synchrotron

    7.2    Beam Transport System

    7.3    Beam Delivery System
    7.3.1    The Passive Scattering Technique
    7.3.2    Beam Scanning

    7.4    Nozzle
    7.4.1    Single Scattering
    7.4.2    Double Scattering
    7.4.3    Uniform Scanning Nozzle
    7.4.4    Pencil Scanning Nozzle

    7.5    Treatment Planning System

    7.6    Image Viewers

    7.7    Patient Positioning System (PPS) 

    7.8    Human Resource

    8.    Global Proton Therapy - Company Analysis (2010-2021) 
    8.1    IBA Proton Therapy
    8.1.1    Sales Analysis

    8.2    Varian Medical Systems
    8.2.1    Sales Analysis

    8.3    Elekta
    8.3.1    Sales Analysis

    9.    Proton Therapy – Driving Factors
    9.1    Technology Advancement

    9.2    Growing Incidence of Cancer Patients in Russia

    10.    Proton Therapy – Challenges
    10.1    Requires Huge Investment

    10.2    Operations Challenges

     


    List of Figures

    Figure 2 1: Russia – Proton Therapy Market (Million US$), 2009 – 2016
    Figure 2 2: Russia – Forecast for Proton Therapy Market (Million US$), 2017 – 2021
    Figure 2 3: Russia – Untapped Proton Therapy Market (Million US$), 2009 – 2016
    Figure 2 4: Russia – Forecast for Untapped Proton Therapy Market (Million US$), 2017 – 2021

    Figure 3 1: Russia – Patient Treated with Proton Therapy (Number), 2009 – 2016
    Figure 3 2: Russia – Forecast for Patient Treated with Proton Therapy (Number), 2017 – 2021
    Figure 3 3: Russia – Untapped Patient for Proton Therapy (Number), 2009 – 2016
    Figure 3 4: Russia – Forecast for Untapped Patient for Proton Therapy (Number), 2017 – 2021

    Figure 8 1: Global – IBA Proton Therapy Sales (Million US$), 2010 – 2016
    Figure 8 2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2017 – 2021
    Figure 8 3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2010 – 2016
    Figure 8 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 – 2021
    Figure 8 5: Global – Elekta Radiation Technology Sales (Million US$), 2010 – 2016
    Figure 8 6: Global – Forecast for Elekta Radiation Technology Sales (Million US$), 2017 – 2021

    Figure 9 1: Russia – Number of Patient Diagnosed With Cancer (Thousand), 2009 – 2016
    Figure 9 2: Russia – Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2017 – 2021


    List of Tables

    Table 3 1: Russia – Proton Therapy Facilities in Operation and in Development Phase

    Table 4 1: Russia – Moscow (ITEP) Proton Therapy Center with Patients Treated (Number), 2007 – 2014
    Table 4 2: Russia – St. Petersburg Proton Therapy Center with Patients Treated (Number), 2007 – 2012
    Table 4 3: Russia – Dubna (JINR, 2) Proton Therapy Center with Patients Treated (Number), 2008 – 2014

    Related Reports

    • Asia Proton Therapy Market & Forecast (Japan, Korea, China) Number of Patients Treated

      Asia Proton Therapy Market is expected to grow with a CAGR of 18 percent in the forecast period. Currently Asia has 15 proton therapy Centers, but in future this number is going to almost double as many proton therapy centers are either in under-construction phase or in planning phase. Japan has the highest market share in proton therapy market, but China and Korea are increasing their market share year on year. ...

      Price: $1,450.00
    • Germany Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers

      Germany Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers is a market research report published by Renub Research. According to this report Germany Proton Therapy Industry has a market potential of US$ 2 Billion by 2021. Currently Germany has 6 operational proton therapy centers. Rising cancer incidence in Germany is the major key driver to boost Germany proton therapy market. Adoption of technological up-gradation that has more utilization rate will shorten t...

      Price: $1,150.00
    • United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast

      UK Proton Therapy Market is expected to grow with a CAGR of 82% in future. United Kingdom Proton Therapy Market is expected to grow 10 times from its current market in 2016. Currently UK has only one Proton Therapy facility, at Clatterbridge cancer center and it’s a ‘low-energy’ machine, only suitable for treating people with rare eye cancers. Treating more complex cancers requires a ‘high-energy’ beam, so the NHS covers the cost of sending patients for treatment overseas (in the US or...

      Price: $1,150.00